Diabetes treatment is constantly evolving, with new therapeutic options developing to improve patient outcomes. Recent studies have focused on GLP-1 and GIP receptor agonists, a group of drugs that mimic the actions https://finnianhuoj835005.wikissl.com/1982103/emerging_glp_1_and_gip_receptor_agonists_a_new_era_in_diabetes_treatment